Meet the Author: Stephen Spellman — ‘Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy — A Report From the CIBMTR’

Stephen Spellman serves as vice president of research within the Center for International Blood and Marrow Transplant Research (CIBMTR) and Clinical Services Department at the NMDP, formerly know as the National Marrow Donor Program, and as senior scientific director of the CIBMTR. In these roles, he oversees the CIBMTR Immunobiology Research Program and leads the CIBMTR Biorepository as principal investigator. His research focuses on the immunobiologic and immunogenetic factors that influence outcomes following hematopoietic cell transplantation and cellular therapy, helping to advance understanding and improve outcomes across the field.

Spellman is the first author of “Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy – A Report From the CIBMTR.”

Watch this video for his perspective.

Visit Transplantation and Cellular Therapy, the official journal of ASTCT, for the full article.

Video Summary:

The “Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy – A report from the CIBMTR” article, published in Transplantation and Cellular Therapy, led by Stephen Spellman provides a comprehensive overview of evolving trends and outcomes in hematopoietic cell transplantation and cellular therapy across the United States, highlighting growth in allogeneic transplant activity, shifts in donor selection, and improved survival over time. Drawing on a decade of national data, the study underscores how advances in GVHD prophylaxis, donor availability, and cellular therapies like CAR T are reshaping clinical practice and expanding access to life-saving treatments.